BR9814958B1 - Proteína de cimento de tecido, composição farmacêutica, uso da proteína de cimento de tecido, vacina, processos para produção de vacina, para ligação de tecido de animal e para preparação de uma protéina de cimento de tecido - Google Patents
Proteína de cimento de tecido, composição farmacêutica, uso da proteína de cimento de tecido, vacina, processos para produção de vacina, para ligação de tecido de animal e para preparação de uma protéina de cimento de tecidoInfo
- Publication number
- BR9814958B1 BR9814958B1 BRPI9814958-0B1A BR9814958A BR9814958B1 BR 9814958 B1 BR9814958 B1 BR 9814958B1 BR 9814958 A BR9814958 A BR 9814958A BR 9814958 B1 BR9814958 B1 BR 9814958B1
- Authority
- BR
- Brazil
- Prior art keywords
- tissue cement
- cement protein
- vaccine
- tissue
- protein
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 7
- 108090000623 proteins and genes Proteins 0.000 title abstract 7
- 239000004568 cement Substances 0.000 title abstract 5
- 241001465754 Metazoa Species 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000004744 fabric Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 230000008569 process Effects 0.000 title 1
- 244000078703 ectoparasite Species 0.000 abstract 3
- 241000894006 Bacteria Species 0.000 abstract 1
- 239000012620 biological material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 230000014599 transmission of virus Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
- C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Insects & Arthropods (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Materials For Medical Uses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9723945.3A GB9723945D0 (en) | 1997-11-12 | 1997-11-12 | Tissue cement |
| PCT/GB1998/003397 WO1999024567A1 (en) | 1997-11-12 | 1998-11-12 | Tissue cement proteins from rhipicephalus appendiculatus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR9814958A BR9814958A (pt) | 2000-10-03 |
| BR9814958B1 true BR9814958B1 (pt) | 2013-10-15 |
Family
ID=10821983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI9814958-0B1A BR9814958B1 (pt) | 1997-11-12 | 1998-11-12 | Proteína de cimento de tecido, composição farmacêutica, uso da proteína de cimento de tecido, vacina, processos para produção de vacina, para ligação de tecido de animal e para preparação de uma protéina de cimento de tecido |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7335733B2 (pt) |
| EP (1) | EP1029044B1 (pt) |
| JP (1) | JP2002505847A (pt) |
| CN (1) | CN1262650C (pt) |
| AT (1) | ATE349520T1 (pt) |
| AU (1) | AU761147B2 (pt) |
| BR (1) | BR9814958B1 (pt) |
| CA (1) | CA2309355C (pt) |
| DE (1) | DE69836759T2 (pt) |
| ES (1) | ES2280105T3 (pt) |
| GB (1) | GB9723945D0 (pt) |
| NZ (1) | NZ504532A (pt) |
| WO (1) | WO1999024567A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1254168A2 (en) * | 2000-02-11 | 2002-11-06 | Evolutec Limited | Cytokine inhibittory molecules from tick salivary glands |
| GB0010068D0 (en) * | 2000-04-25 | 2000-06-14 | Evolutec Limited | Vaccine composition |
| EP1283716B1 (en) * | 2000-04-25 | 2012-03-28 | Merial Limited | Vaccine comprising a tick cement protein |
| ES2446984T3 (es) * | 2001-01-04 | 2014-03-11 | University Of Saskatchewan | Vacuna contra Escherichia coli enterohemorrágica |
| EP1443958B1 (en) * | 2001-10-08 | 2010-12-08 | Merial Limited | Vaccine against infectious disease |
| GB0321331D0 (en) * | 2003-09-12 | 2003-10-15 | Constr Res & Tech Gmbh | Accelerator composition for accelerating setting and/or hardening a cementitious composition |
| GB0416791D0 (en) * | 2004-07-28 | 2004-09-01 | Constr Res & Tech Gmbh | Setting accelerator for sprayed concrete |
| PT1878713E (pt) * | 2006-07-14 | 2009-05-25 | Constr Res & Tech Gmbh | Dispersão estável de acelerador para betão projectado, com um elevado teor de matéria activa |
| WO2012127383A1 (en) | 2011-03-18 | 2012-09-27 | Ecolab Usa Inc. | Heat system for killing pests |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2142334B (en) * | 1983-03-14 | 1986-08-28 | Int Centre Of Insect Physiolog | Immunogenic preparations |
-
1997
- 1997-11-12 GB GBGB9723945.3A patent/GB9723945D0/en not_active Ceased
-
1998
- 1998-11-12 AU AU10471/99A patent/AU761147B2/en not_active Expired
- 1998-11-12 BR BRPI9814958-0B1A patent/BR9814958B1/pt active IP Right Grant
- 1998-11-12 ES ES98952929T patent/ES2280105T3/es not_active Expired - Lifetime
- 1998-11-12 JP JP2000520562A patent/JP2002505847A/ja active Pending
- 1998-11-12 WO PCT/GB1998/003397 patent/WO1999024567A1/en active IP Right Grant
- 1998-11-12 NZ NZ504532A patent/NZ504532A/xx not_active IP Right Cessation
- 1998-11-12 CN CNB988129396A patent/CN1262650C/zh not_active Expired - Lifetime
- 1998-11-12 CA CA2309355A patent/CA2309355C/en not_active Expired - Lifetime
- 1998-11-12 DE DE69836759T patent/DE69836759T2/de not_active Expired - Lifetime
- 1998-11-12 EP EP98952929A patent/EP1029044B1/en not_active Expired - Lifetime
- 1998-11-12 AT AT98952929T patent/ATE349520T1/de not_active IP Right Cessation
-
2002
- 2002-08-23 US US10/226,489 patent/US7335733B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CN1262650C (zh) | 2006-07-05 |
| GB9723945D0 (en) | 1998-01-07 |
| EP1029044A1 (en) | 2000-08-23 |
| NZ504532A (en) | 2002-11-26 |
| AU761147B2 (en) | 2003-05-29 |
| ES2280105T3 (es) | 2007-09-01 |
| CA2309355C (en) | 2011-04-05 |
| WO1999024567A1 (en) | 1999-05-20 |
| DE69836759T2 (de) | 2007-10-04 |
| BR9814958A (pt) | 2000-10-03 |
| CA2309355A1 (en) | 1999-05-20 |
| DE69836759D1 (de) | 2007-02-08 |
| US20030078390A1 (en) | 2003-04-24 |
| US7335733B2 (en) | 2008-02-26 |
| EP1029044B1 (en) | 2006-12-27 |
| CN1284995A (zh) | 2001-02-21 |
| ATE349520T1 (de) | 2007-01-15 |
| JP2002505847A (ja) | 2002-02-26 |
| AU1047199A (en) | 1999-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0113822A (pt) | Vacina | |
| ATE309271T1 (de) | Zusammensetzungen von kollagenbindungsprotein und verfahren zur deren verwendungen | |
| ATE286067T1 (de) | Hcv hüllproteine partikel : verwendung für therapeutische impfung | |
| NO20004972D0 (no) | Derivater av pneumokokkiske kolinbindende proteiner | |
| CY1105221T1 (el) | Ιατρικη χρηση θυρεοειδομιμητικων ενωσεων για την θepαπευτικη αγωγη της τριχοπτωσης και φαρμακευτικες συνθεσεις | |
| DE60121136D1 (de) | Proteasom-influenzavirus-impfstoffzusammensetzung | |
| DE69940404D1 (de) | Multikomponenten Impfstoffe gegen Staphylococcus aureus | |
| CY1110727T1 (el) | Παρασκευασματα θετικων κατα gram βακτηριων για τη θεραπεια ασθενειων που περιλαμβανουν μια ανοσολογικη δυσρυθμιση | |
| PT957935E (pt) | Vacinas e composicoes imunogenicas contra clamidia contendo um antigenio de membrana externa e metodos para a sua preparacao | |
| BR0012919A (pt) | Vacina para uso na profilaxia e/ou no tratamento da sìndrome de ponto branco (white spot syndrome) em crustáceos, proteìna estrutural derivada do vìrus da sìndrome de ponto branco, sequência de ácido nucléico, uso de uma proteìna estrutural, composição farmacêutica, anticorpos, vacina ou formulação farmacêutica, e, kit diagnóstico para detecção de wssv | |
| BR9814958B1 (pt) | Proteína de cimento de tecido, composição farmacêutica, uso da proteína de cimento de tecido, vacina, processos para produção de vacina, para ligação de tecido de animal e para preparação de uma protéina de cimento de tecido | |
| CY1114614T1 (el) | Αντιγονα αιμοφιλου ινφλουεντσας και αντιστοιχα dna θραυσματα | |
| ATE473236T1 (de) | Antigene von piscirickettsia salmonis und deren verwendung | |
| BR0206995A (pt) | Tratamento do vìrus da hepatite b | |
| BR0110278A (pt) | Composição de vacina, anticorpo ou anti-soro, métodos de produção de um anticorpo ou de um anti-soro e de imunização de um animal contra um ectoparasita que se alimenta de sangue, proteìna de cemento de carrapato, e, uso de uma proteìna de cemento de carrapato | |
| CY1107560T1 (el) | Ζωντανα εξασθενημενα βακτηρια για χρηση σε εμβολιο | |
| BR0100954A (pt) | Utilização de o-vanilina e combinações deo-vanilina/trolox(r) | |
| DE60007973D1 (de) | Matrixprotein zusammensetzungen für pfropfung in nicht mineralisierten geweben | |
| BR9808226A (pt) | Coronavìrus respiratório bovino como uma vacina | |
| DE602004025103D1 (de) | Heilkräuterzusammensetzung zur Behandlung von AIDS | |
| PT1173194E (pt) | Sp-a recombinante para o tratamento ou a prevencao da infeccao e da inflamacao pulmonares | |
| ATE353226T1 (de) | Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form | |
| CY1108761T1 (el) | Απενεργοποιημενες κυτοκινες για ανοσοποιηση | |
| BR0110791A (pt) | Composição, métodos para induzir uma resposta imune em um indivìduo contra um imunogene, para modular o sistema imune de um indivìduo e para imunizar um indivìduo contra um patógeno, vacina recombinante, e patógeno atenuado vivo | |
| BR0215719A (pt) | Proteìnas com domìnios bacterianos repetitivos semelhantes a ig (big) presentes em espécies de leptospira |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Transfer |
Free format text: EVOLUTEC LTD (GB) |
|
| B25G | Requested change of headquarter approved |
Owner name: EVOLUTEC LTD. (GB) Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020060062216/RJ DE 03/05/2006. |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B25C | Requirement related to requested transfer of rights |
Owner name: EVOLUTEC LTD. (GB) Free format text: A FIM DE ATENDER A TRANSFERENCIA SOLICITADA ATRAVES DA PET. NO 020100074182-RJ, DE 11/08/2010, E NECESSARIO REAPRESENTAR O DOCUMENTO DE CESSAO DEVIDAMENTE CONSULARIZADO. |
|
| B25A | Requested transfer of rights approved |
Owner name: MERIAL LIMITED (GB) Free format text: TRANSFERIDO DE: EVOLUTEC LIMITED |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI. |
|
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 15/10/2013, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B25G | Requested change of headquarter approved | ||
| B25A | Requested transfer of rights approved | ||
| B25A | Requested transfer of rights approved |